UPDATED
Dec 17
New Users Please Click to Register
Renew or Upgrade your Existing  Account
UPDATE EMAIL
CHANGE PASSWORD
CHECK STATUS
CHECK PASSWORD

DISCLOSURE
BOOKMARK-HDCN
VBOOTHS
ABOUT OUR SITE
SYMPOSIA
FREE ZONE INDEX
ABSTRACTS
BY DATE
BY TOPIC
SEARCH HDCN
JOURNALS
SOCIETIES, LINKS
CLINICAL TRIALS
HYPERTENSION
DIALYSIS-CRF
CLIN NEPHROL
FREE ZONE
KEY ZONE
SEARCH

VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
Slides/audio/handouts:    ADC-2009(a)  :  ASDIN-2009(s/a/h)  :  RRI-2009(s/a/h)  :  ASN-2008(a)  :  NANT-2009(a)  :  ADC-2008(a)  :  Network9,10-2008(s/a/h)  :  RPA-2008(s/a/h)  :  ASDIN-2008(s/a/h)  :  RRI-2008(s/a/h)  :  ASN-2007(a)  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  

Bonsib  

Hudes  

  Renal Neoplasms: What the Nephrologist Should Know Flash slide/audio
(ASN Renal Week Clinical Nephrology Conference Extract, November, 2008)
Bonsib: What are the basic types of renal neoplasms? What is their incidence, and what are the risk factors? What is the relationship between renal cysts and renal neoplasms? Which are the benign and malignant diffusely cystic renal neoplasms? What's the association between autosomal dominant polycystic kidney disease and renal cancer? What do nephrologists need to know about von Hippel-Lindau disease? Tuberous sclerosis? What's new in acquired cystic disease of CKD and transplant? When and how should these patients be screened? What are 2 new tumor types associated with this condition? Hudes: What are the latest data with regard to cytokine (interleukin-2 and interferon) therapy for renal cell carcinoma? What are the results with bevacizumab, sorafenib, sunitinib, temsirolimus, and everolimus? How does tumorigenesis progress and how might these new agents inhibit this process? How is the mTOR signalling pathway involved? What are the risks and adverse events with these newer therapies?
(more...)


Agarwal  

Kalantar  

  Controversies in Anemia Management of Chronic Kidney Disease Patients Flash slide/audio
(ASN Renal Week Official Symposium, October, 2009)
Agarwal: How does iron deficiency impact erythropoiesis and what are the causes of iron loss in ESRD patients? How is gut iron absorption regulated? How does one interpret the serum ferritin and TSAT in CKD? What are the risks of hemoglobin normalization? How does hepcidin regulate iron? Kalantar-Zadeh: How did the KDOQI anemia guidelines changes in 2006? In 2007? Where does transferrin come from? What are the normal values? How does TIBC associated with nutritional status? How does TIBC associate with survival in both cross-sectional and time-varying analyses? How dose TSAT associate with mortality. Is this different in predialysis patients? How is the platelet count related to TSAT? What is the structural pharmacology of ferritin? How is it related to malignancy, malnutrition, and CRP? What are the effects of ferritin on vascular calcification? What are the mortality implications of various ratios of TSAT/ferritin? At what level of ferritin and TSAT is ESA responsiveness the greatest?
(more...)


Boulware  

Sedor  

Norris  

  Racial Disparities in Patients with Chronic Kidney Disease Flash slide/audio
(ASN Renal Week Official Symposium, October, 2009)
Boulware: How does the increased incidence of ESRD in Blacks compare to other ethnic groups, esp. Native Americans and Hispanics? What are the ethnic associations with albuminuria; with hypertension at various stages of CKD? How does the rate of CKD progression compare in Blacks vs. Caucasians? How does access to care and time of referral affect the ethnic effect on progression? How does ethnicity affect wait-listing for transplant, or likelihood of a living donor transplant? Sedor: How do we map genes to find gene-disease associations? What is the MALD technique? To what extent are race and genetics compatible concepts? How does MYH9 gene prevalence illustrate these concepts? Norris: How do environmental components contribute to racial disparities in CKD? How does psychological stress associate with oxidative stress? To what extent is air pollution involved; exposure to heavy metals; organic pollutants; smoking and substance abuse?
(more...)


Rosner  

Sterns  

Palmer  

  Innovations in Caring for Patients with Hyponatremia Flash slide/audio
(ASN Renal Week Official Symposium, October, 2009)
Rosner: How is hyponatremia related to morbidity, gait abnormalities, fractures and falls, and in-hospital mortality? Is resolution of hyponatremia associated with improved outcomes? Do management errors affect the prognosis? Sterns: In terms of management of hyponatremia, how much correction is enough? How much correction is too much? What do animal studies show us about chronic hyponatremia and myelinolysis? Is myelinolysis reversed by reintroduction of hyponatremia? What is the recommended therapy for acute water intoxication? What patients need to be treated acutely? What should be the therapeutic goal? What are the risk factors for osmotic demyelination syndrome? Palmer: What are the various treatment strategies for chronic hyponatremia? What are the advantages and limitations of each? What are current indications for conivaptan and tolvaptan? What are potential benefits of treating hyponatremia in terms of risk of falls, quality of life, and cognition? How does CYP2D6 gene expression modulate hyponatremia due to antidepressants? How are polymorphisms of the TRPV4 gene involved? What causes the nephrogenic syndrome of inappropriate diuresis? What are results of vasopressin antagonists in congenital nephrogenic DI, in Meniere's disease? What are potential future uses of V2R antagonists?
(more...)


Hypertension, Cardiovascular
Salt intake and stroke
Dabigatran vs. warfarin for venous thromboembolism
CKD, ESRD
Exercise for CKD patients
High-dose losartan better for CHF
Heartmate II LVAD for bad CHF
Dialysis and repeat myocardial stunning
Online HDF better than high flux HD
Treating depression in diabetics lowers A1C
Acrylamide bad
CMV and ESA resistance
LV geometry predicts bad outcome with ESA and high Hb
Adding ARB or aldo to ACEI in diabetic nephropathy
25-D levels and progression
Uremic toxins from bugs in the colon
Convective therapies review
Clinical Nephrology
Acute hemolysis after IVIG in sensitized patients
Cardiorenal syndrome review
mTOR in renal disease
Measuring protein excretion in lupus
Nephrin mutations and FSGS



ANNA CE

(Article Free, $CE)
ANNA CE (NNJ)
Target audience: Nurses. Article free, CE requires payment to ANNA via HDCN.

Pictures and Perspectives: A Unique Reflection on Interdialytic Weight Gain
(Vol 36/No. 6. Expires 12/20/2011)
Peter M. Sinclair, RN, and Vicki Parker, PhD, RN
1.1 hr

A Qualitative Analysis of Patient Reported Symptoms of Anemia
(Vol 36/No. 6. Expires 12/20/2011)
Kathryn F. Lasch, PhD, Christopher J. Evans, PhD, and Dori Schatell, MS
1.1 hr

Lethality of Endocarditis Due To S. Aureus among Patients On Hemodialysis
(Vol 36/No. 6. Expires 12/20/2011)
Cibele Grothe, MSc, Angélica Belasco, PhD, Ana Bettencourt, PhD, Solange Diccini, PhD, Lucila Vianna, PhD, Antonio Pignatari, MD, Ricardo Sesso, MD, and Dulce Barbosa, PhD
1.4 hr

African-American Women’s Perceived Health Status While Caring for a Relative with End Stage Renal Disease
(Vol 36/No. 6. Expires 12/20/2011)
Dina J. Byers, PhD, ARNP, CNS-C, Tamara Harris Beard, PhD, FNP, and Mona N. Wicks, PhD, RN
1.4 hr




Annual Dialysis Conference 2009
now in MP3
AUDIOFILE LIST (Annual Dialysis Conference 2009)
(14 talks)
Home Hemodialysis
Christopher R. Blagg, MD, Michael Aragon, MD, Sylvia Donato-Moore, BSN, RN, CNN, Michelle Carver, BSN, RN,CNN, Dorian Schatell, MS, Linda Upchurch, BS, MBA, and Joel Glickman, MD

Elderly PD Patients
Allen Nissenson, MD, Dimitrios Oreopoulos, MD, Matthew Oliver, MD, and Allen Nissenson, MD

Dialysis Technology: Present and Future
Andrew Davenport, MD; James Winchester, MD; and Ingrid Ledebo, PhD


Hypertension, Cardiovascular:
None this update.

Dialysis, CKD:
Contrast dye for fistulography and Kru; Vibrating the dialyzer enhances Kd; Reticulocytosis and EPO resistance; New citrate anticoagulation device; Self-reported urine output in ESRD; ECF volume and mortality; Dialysate K and cardiac arrest; Need to calibrate dialysate Na; Bioimpedance vs. reference methods; 3-hr 6/week dialysis benefits long-term; Scottish nephrologists' preferences for dialysis; Dextrose load due to ACD-A in citrate anticoagulation; pre- vs. postdilution CVVH; Nafamostat mesilate for CVVH; Removing AGEs; Predialysis hyponatremia and mortality; CV events in AURORA; Abdominal aorta calcification bad; Abdominal obesity, glycosylated Hb, CRP, and outcomes; Higher dialysis doses in Japanese women good; Strategies to increase influenza vaccination; Waist-to-hip in PD; Interferon/ribavirin in ESRD; Hb protocols, Hb sampling, use of postdialysis Hb; rHuEPO dosing errors due to concentrated vials; RBC lifespan and inflammation; 25-D levels and ESA resistance; Hepcidin and response to IV iron; GLA protein and calcification; CaC03 vs. Ca acetate; Ferric citrate as a Pi binder; Empirical treatment of tuberculosis; Calcification index and mortality; LDL particle size; Intracranial carotid artery calcification and stroke risk; Ethnicity and hemorrhagic stroke; Bilateral symmetry in uremic itching.

Clinical Nephrology:
Smoking and cystatin GFR; Cystatin C assays compared; Cystatin C vs. creatinine; Low incidence of RCC in ADPKD.  (more...)


    Hit reload / refresh
Login stopped working? Bouncing email logins suspended.
Slide/audio problem when lectures played with legacy options using Windows Media or Real Player.
HDCN_RSS  Click on RSS for details of each news story.
Updated: December 23, 2009 (Dec23)
Dec23 Caloric restriction longevity effects linked to telomerase activity.
Dec23 INF2 gene mutations linked to focal segmental glomerulosclerosis (FSGS)
Dec23 American Heart Association's selection of top 10 research advances
Dec23 Intestinal liner to treat type 2 diabetes and obesity approved for sale in Europe.
Dec23 Aggressive BP treatment in patients over 80 may result in increased mortality.
Dec22 Dr. Tom Parker III awarded AAKP's 2010 Medal of Excellence Award
Dec22 Adenylyl cyclase senses bicarbonate levels and regulates blood pH (in dogfish shark)
Dec22 Deoxycytidine kinase enzyme shown to profoundly affect adaptive immune system.
Dec22 Neuropeptide Y receptors on osteoblasts are evidence of how brain and diet control bone formation.
Dec21 Facebook post brings Iowa man a new kidney.
Dec21 24-h BP monitoring disturbs sleep in some, artifactually affecting the amount of nocturnal BP dipping.
Dec21 Genetic studies clarify differing European and West African components of inheritance in African Americans
Dec17 HDCN: Renal cancers, Anemia, Race and ESRD, New approaches to hyponatremia, more ADC talks, 50 more RW09 abstracts.
Dec17 Physicians advocate for repeal of Medicare sustainable growth rate approach.
Dec17 House votes to delay Medicare physician reimbursement reductions until March.
Dec16 Mostly immigrant dialysis patients lose lawsuit against closure of Grady dialysis unit.
Dec16 Scientists crack genetic code of skin and lung cancer.
Dec16 RPA final comments on ESRD prospective payment system.
Dec15 Kidney Care Partners letter to senators regarding immunosuppressive drug reimbursement issues.
General Advances Emphasis
archive
The role of the mammalian target of rapamycin (mTOR) in renal disease
Lieberthal and Levine review how mTOR is involved in recovery from renal injury, diabetic nephropathy, cystic diseases of the kidney, and renal carcinoma; in the December issue of the J Am Soc Nephrol (CJASN) (more...)

Cardiorenal syndrome in acute decompensated heart failure
Sarraf, Maoumi and Schrier review pathogenesis and various possible treatments, in the December issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence
Thomas and Jaber look critically at the data for use of hemodiafiltration and other convective therapies in both acute and chronic situations; in the Nov/Dec issue of Seminars in Dialysis. (more...)

Interstitial cystitis: an unsolved enigma
Moutzouris and Falagas review the diagnosis of IC, the role of specific and supportive therapies, and directions for future research, in the November issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

MASTering Treg function to promote tolerance
Levings and Thomson discuss a paper by Noelle in which rejection of skin grafts was treated by activation of mast cells in a T-cell mediated process; in the October issue of the Am J Transplant. (more...)

The Declaration of Istanbul: Review and commentary by the American Society of Transplant Surgeons Ethics Committee and Executive Committee
Reed et al talk about the issues in applying the principles in this declaration to the North American setting; in the November issue of the Am J Transplant. (more...)

Encapsulating peritoneal sclerosis: Importance to the hemodialysis practitioner
In this Trainee Forum, Perl, Bargman and Chan tell us why peritoneal sclerosis is such an important issue to long-term PD and what we can do about it; in the October 2009 issue of the Hemodial Int (more...)

Mineralocorticoid receptor blockers and chronic kidney disease
Jain and colleagues review the scientific basis for renoprotection by blocking mineralocorticoid receptors, including a discussion of risks and benefits of current treatments; in the October issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

450+
  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

Boots on the Ground: Do We Have Enough Personnel to Fight the Battle Against CKD? (Wish and Piraino)
Controversies in Vascular Access (Asif and Urbanes)
ASDIN: 5th Annual Scientific Meeting, February, 2009.
Nephrology Quiz and Questionnaire: Fluids and Electrolyte and Glomerular Disorders (Palmer and Pusey)
Primary Care in Nephrology: Preoperative Risk Assessment and Management of Glycemic Control (Golper and Mordes)
IgA Nephropathy: Time to Change Our Approach? (Feehally and Hogg)
Advances in CKD 2009 (various speakers)
CKD Care and Your Practice Culture: Improve Your Performance! (Maddux, Molony, Kliger, Blaser, et al)
The Sexual Life Cycle of Women with CKD (Yao, Hou, Kurella-Tamura)
Resistant Hypertension: A Challenge for the Nephrologist (Campese and Steigerwalt)
New Frontiers in Phosphorus Homeostasis in CKD (Quarles, Wolf)
Care of the Chronic Kidney Disease Patient (Campbell, Berns, Batlle)
Managing CKD-MBD through the Disease Continuum (Thadhani, Kestenbaum)
Restoring Balance: New Therapeutic Approaches to Acute Decompensated Heart Failure (Goldberg, Schrier, and Gheorghiade)
The Year in Nephrology: Hypertension and Metabolic Renal Syndrome (Griffin and Beddhu)
Nephrology Roundtable: Glucose Transport and Targets for Intervention (De Zeeuw, Wright)
Acute Renal Replacement Therapy (Palevsky)
The ESA Controversy: The Role of Intravenous Iron (Ganz, Agarwal, Besarab)
Shades of Grey: Key Questions in the Future of Treatment for CKD-Related Anemia (Schmidt, Toto, Norris)
Gammopathies and the Kidney and Thrombotic Microangiopathy (Falk)
Ischemic Nephropathy: Diagnosis and Management (Textor)
Disorders of Calcium and Phosphorus Metabolism (Wolf)
FREE
Managing Anemia in Chronic Kidney Disease: The Benefits to Patients (Schira)
  Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)
Nephrology Quiz and Questionnaire: Fluid and Electrolyte and Glomerulonephritis Cases (Emmett and Radhakrishnan)
Controversies in Diagnosis and Treatment of Atherosclerotic Renovascular Disease (Textor and Dworkin)
FREE
What You Can Teach Your Team About Chronic Kidney Disease-Related Mineral Bone Disorder (CKD-MBD) (Schmidt and Senft)
New Insights, Treatments, and Management Strategies for ADPKD (Chapman and Calvet)
FREE
Stabilizing Hemoglobin Levels: What's New in IV Iron and Anemia Management? (Fishbane, VanBuskirk, Larson)
Novel Therapeutics for Fluid and Electrolyte Disorders (Verbalis and Palmer)
DILEMMAS IN THE TREATMENT OF GLOMERULAR DISEASE:
Treatment of Frequently Relapsing/Steroid Dependent Minimal Change Disease (Hogg);
Evaluation and Treatment Approach to Steroid-Resistant Primary FSGS in Adults (Meyrier).
Congestive Heart Failure: A Nephrologist's Disease? (Murray)
AKI Therapeutics: From Bench to Commercialisation (Molitoris)
FREE
New Perspectives on the Progression of Coronary Artery Calcification and Patient Outcomes in Chronic Kidney Disease (Qunibi, Szczech)
Renal Disease and the Metabolic Syndrome (Muntner and Fried)
Nephrolithiasis (Worcester and Lieske)
The Genetics of FSGS (Hildebrandt and Kaskel)
Primary Care Issues in Nephrology: Peripheral Vascular Disease: Assessments and Approaches to Care (Froehlich); Rheumatology for Nephrologists (Kay).
Achieving Control: Optimizing the Management of CKD-Anemia (Nissenson, Fishbane, Germain, and Provenzano)
Mycophenolate in Lupus and Non-Glomerular Renal Diseases (Shaw and Appel)
  ASDIN Annual Meeting 2008
  RPA Annual Meeting 2008
  Advances in CKD 2008 (RRI 10th Annual International Dialysis Symposium
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008 (Qunibi and Nolan)
Aldosterone: New Insights in Kidney Health and Disease (Calhoun and Rosenberg)
Pre-ESRD and Mineral Metabolism (Martin and Moe)
New Insights into Common Problems After Kidney Transplantation (Kasiske and Weisinger)
Challenges and Opportunities in the Treatment of Hyperuricemia and Gout (Terkeltaub, Rich, Feig)
New Treatments for Diabetes Mellitus: Implications for Clinicians (Nelson and Bakris)
The Aging Kidney (Fliser and Aronoff)
Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions (London, Langman, Ketteler)
Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction (Burnett, Fowler, Gheorghiade)
Cardiovascular Disease in End Stage Renal Disease Patients (Henrich)
Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis (Persson, Knopp, Perazella)
New Developments in Anemia Management in Chronic Kidney Disease (Roy, Besarab, Amerling, Berns)
The Cystic Diseases (Bennett)
Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia (Berns, Provenzano, Szczech)
Critical Care Nephrology (Murray)
FREE
Chronic Kidney Disease - Mineral Bone Disorder (Arruda, Snavely)
Electrolyte/Acid-Base Emergencies in the ICU (Palmer)
Nocturnal and Frequent Dialysis: Are These the Preferred Therapies for Patients with Cardiovascular Disease?
FREE
Updating Practices in an Evolving IV Iron and Anemia Environment: Practical Solutions. A New Anemia Treatment Paradigm in Favor of the Patient (Easom, Juergensen, Amerling)
Sudden Death in Hemodialysis Patients: Epidemiology
Diabetes and Non-insulin Management in CKD
Obesity and Outcomes in Dialysis Patients
Is Obesity a Risk Factor for the Development And Progression of Chronic Kidney Disease?
FREE
Standards: The Basis of Care to Manage the Patient with Complications of Chronic Kidney Disease Leading to Cardiovascular Disease (Burrows-Hudson, Headley, Campoy)
FREE
Achieving and Maintaining a Phosphate Balance in the Patient With CKD (Mathers)
Cocaine and Chronic Kidney Injury
Proton Pump Inhibitors and the Kidney: Critical Review
Characteristics of the Long-Term Peritoneal Dialysis Patient
Prospects and Challenges for a Staphylococcal Vaccine
Alternatives to Vancomycin in the Treatment of Gram-Positive Cocci
Overview of Catheter Lock Solutions
Are ACE inhibitors and ARBs Essential to Renoprotection? Debate.
Early Anemia Management: Incorporating New Evidence Into Appropriate Treatment Strategies for Chronic Kidney Disease
3rd Annual Scientific Meeting of the ASDIN. April, 2007.
Improving Efficiency in the Nephrologist's Office. RPA Annual Meeting (2007)
RRI Ninth International Conference on Dialysis, January, 2007. Part Four
Bone and Mineral Metabolism in CKD: Medical Crossfire
RRI Ninth International Conference on Dialysis, January, 2007. Part Three
Fluid Dysregulation: Disturbances and Management
RRI Ninth International Conference on Dialysis, January, 2007. Part Two
Inflammation in CKD: Biomarkers, Morbidity and Therapy
Managing CMV Infections in Transplantation
RRI Ninth International Conference on Dialysis, January, 2007. Part One
Disorders of Sodium Metabolism: Case Presentations
The CKD that Follows Renal Transplantation: How to Best Manage these Patients?
Transplant Biopsy
The New KDOQI Guidelines for Anemia; Debate: Should an Upper Hgb Limit be Set and What Should it Be?
Calcimimetics: Monotherapy for Secondary Hyperparathyroidism?
Lupus Nephritis: Defining and Treating Renal Flares
Secondary Hypertension, including Chronic Kidney Disease
New, Tri-Partite Approach to Anemia
Magnesium Balance: Hypomagnesemia and Hypermagnesemia
Pathogenesis and Management of Cardiovascular Disease (CVD) in Chronic Kidney Disease
Transplantation: Medical and Immunosuppressive Management
  Using Technology to Improve the Quality of Care (target audience: technicians)
more...











 
Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

Warning-Disclaimer:
The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented in this journal/server.

Copyright statement:
Copyright - 1995 - 2008 by Medtext, Inc. All rights reserved. No part of the material on this journal/server may be reproduced in any form or by any electronic or mechanical means, including information storage and retrieval systems, without permission in writing from the publisher, except by a reviewer who may quote brief passages in a review.

Published by Medtext, Inc., Burr Ridge, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99